BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26628725)

  • 1. Musser et al. Reply to "Emergence of the Same Successful Clade among Distinct Populations of emm89 Streptococcus pyogenes in Multiple Geographic Regions".
    Musser JM; Zhu L; Olsen RJ; Nasser W
    mBio; 2015 Dec; 6(6):e01838-15. PubMed ID: 26628725
    [No Abstract]   [Full Text] [Related]  

  • 2. Turner et al. Reply to "Emergence of the Same Successful Clade among Distinct Populations of emm89 Streptococcus pyogenes in Multiple Geographic Regions".
    Turner CE; Lamagni T; Holden MT; David S; Jones MD; Game L; Efstratiou A; Sriskandan S
    mBio; 2015 Dec; 6(6):e01883-15. PubMed ID: 26628727
    [No Abstract]   [Full Text] [Related]  

  • 3. Emergence of the Same Successful Clade among Distinct Populations of emm89 Streptococcus pyogenes in Multiple Geographic Regions.
    Friães A; Machado MP; Pato C; Carriço J; Melo-Cristino J; Ramirez M
    mBio; 2015 Dec; 6(6):e01780-15. PubMed ID: 26628724
    [No Abstract]   [Full Text] [Related]  

  • 4. Emergence of a New Highly Successful Acapsular Group A Streptococcus Clade of Genotype emm89 in the United Kingdom.
    Turner CE; Abbott J; Lamagni T; Holden MT; David S; Jones MD; Game L; Efstratiou A; Sriskandan S
    mBio; 2015 Jul; 6(4):e00622. PubMed ID: 26173696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clone of the emergent Streptococcus pyogenes emm89 clade responsible for a large outbreak in a post-surgery oncology unit in France.
    Plainvert C; Longo M; Seringe E; Saintpierre B; Sauvage E; Ma L; Beghain J; Dmytruk N; Collobert G; Hernandez E; Manuel C; Astagneau P; Glaser P; Ariey F; Poyart C; Fouet A
    Med Microbiol Immunol; 2018 Nov; 207(5-6):287-296. PubMed ID: 29936564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Characteristics Behind the Spread of Bacteremic Group A Streptococcus Type emm89 in Finland, 2004-2014.
    Latronico F; Nasser W; Puhakainen K; Ollgren J; Hyyryläinen HL; Beres SB; Lyytikäinen O; Jalava J; Musser JM; Vuopio J
    J Infect Dis; 2016 Dec; 214(12):1987-1995. PubMed ID: 27707808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trading Capsule for Increased Cytotoxin Production: Contribution to Virulence of a Newly Emerged Clade of emm89 Streptococcus pyogenes.
    Zhu L; Olsen RJ; Nasser W; de la Riva Morales I; Musser JM
    mBio; 2015 Oct; 6(5):e01378-15. PubMed ID: 26443457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome sequence analysis of emm89 Streptococcus pyogenes strains causing infections in Scotland, 2010-2016.
    Beres SB; Olsen RJ; Ojeda Saavedra M; Ure R; Reynolds A; Lindsay DSJ; Smith AJ; Musser JM
    J Med Microbiol; 2017 Dec; 66(12):1765-1773. PubMed ID: 29099690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outbreak of
    Hayama B; Harada S; Suzuki M; Doi Y; Nomura Y; Aoki K; Takehana K; Akatsuchi T; Enokida T; Takeda K; Seto A; Mitani H; Ohkushi D
    Microbiol Spectr; 2024 May; 12(5):e0426023. PubMed ID: 38587390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of clinically isolated Streptococcus pyogenes from balanoposthitis patients, with special emphasis on emm89 isolates.
    Hasegawa T; Hata N; Matsui H; Isaka M; Tatsuno I
    J Med Microbiol; 2017 Apr; 66(4):511-516. PubMed ID: 28463666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A report on the first outbreak of emm89 group A streptococcus invasive infections in a burns unit in Tunisia.
    Mnif B; Sallem N; Triki Z; Hammami A
    J Med Microbiol; 2019 Oct; 68(10):1540-1543. PubMed ID: 31483245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T serotyping of Streptococcus pyogenes in Aichi Prefecture, Japan isolated between 2003 and 2007.
    Matsumoto M; Yamaguchi I; Sasano M; Hori M; Ikezaki K; Shimizu S; Nishiyama Y; Sato N; Tsuchiya H; Suzuki M; Minagawa H;
    Jpn J Infect Dis; 2009 Mar; 62(2):168-9. PubMed ID: 19305064
    [No Abstract]   [Full Text] [Related]  

  • 13. High-resolution genotyping of Streptococcus pyogenes. Application to outbreak studies and population genetics.
    Stanley J; Desai M; Efstratiou A; George R
    Adv Exp Med Biol; 1997; 418():313-6. PubMed ID: 9331659
    [No Abstract]   [Full Text] [Related]  

  • 14. Bacteriological and molecular studies of group A streptococcal pharyngitis in a south Indian hospital.
    Sindhulina C; Geethalakshmi S; Thenmozhivalli PR; Jose JM; Brahmadathan KN
    Indian J Med Microbiol; 2008; 26(2):197-8. PubMed ID: 18445967
    [No Abstract]   [Full Text] [Related]  

  • 15. A change in pattern of group G streptococcal septicaemia?
    Meigh JA; Wilson JA; Meigh RE; Mawer SL
    J Infect; 2002 Feb; 44(2):139. PubMed ID: 12076075
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biotypes and antimicrobial susceptibility of Streptococcus pyogenes strains isolated in children in Tunis].
    Ksia S; Smaoui H; Hariga D; Kechrid A
    Bull Soc Pathol Exot; 2010 May; 103(2):69-74. PubMed ID: 20390396
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution of the serotypes of group A streptococci in Bulgaria from 1968 till 1996.
    Detcheva AD
    Adv Exp Med Biol; 1997; 418():227-8. PubMed ID: 9331638
    [No Abstract]   [Full Text] [Related]  

  • 18. High prevalence of fluoroquinolone-nonsusceptible Streptococcus pyogenes emm12 in Taiwan.
    Lin JN; Chang LL; Lai CH; Huang YH; Chen WF; Yang CH; Hsu J; Lin HH; Chen YH
    Diagn Microbiol Infect Dis; 2015 Oct; 83(2):187-92. PubMed ID: 26234479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal analysis of five M types causing most disease in New Zealand.
    Martin D; Kakani J; Szeto J
    Adv Exp Med Biol; 1997; 418():331-3. PubMed ID: 9331663
    [No Abstract]   [Full Text] [Related]  

  • 20. Nosocomial outbreak of Streptococcus pyogenes puerperal sepsis.
    Cabal A; Schmid D; Lepuschitz S; Stöger A; Blaschitz M; Allerberger F; Ruppitsch W; Hell M
    Clin Microbiol Infect; 2019 Apr; 25(4):521-523. PubMed ID: 30593861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.